Login to Your Account

Heptares $21M Series B Paves Way for Phase I in CNS Disorders

By Nuala Moran
Staff Writer

Wednesday, July 3, 2013
LONDON – Heptares Ltd. has raised $21 million in a Series B funding co-led by the Stanley Family Foundation, one of the leading foundations investing in neuroscience diseases.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription